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ABSTRAK 
TARIGAN, S. 2005. Nilai proteksi respon imun pada kambing yang divaksin dengan protein nirlarut dari Sarcoptes scabiei. JITV 
10(2): 118-126. 
Vaksin yang dikembangkan dari protein membran yang berasal dari permukaan lumen usus artropoda telah dibuktikan 
efektif untuk mengendalikan beberapa artropoda. Pendekatan yang sama kemungkinan dapat juga diterapkan pada Sarcoptes 
scabiei karena parasit ini juga telah terbukti menghisap imunoglobulin induk semangnya. Untuk mengevaluasi protektif imunitas 
dari protein membran S. scabiei, protein ‘nirlarut’ tungau diekstraksi berturut-turut dalam larutan: 1.14 M NaCl, 2% SB 3-14 
Zwitterion detergent, 6 M urea, 6 M guanidine-HCl dan 5% SDS. Lima kelompok kambing (6 atau 7 ekor per kelompok) 
masing-masing divaksin dengan fraksi protein tersebut. Vaksinasi dilakukan sebanyak 6 kali, masing-masing dengan dosis 250 
µg protein dengan interval 3 minggu antara vaksinasi. Kelompok 6 (7 ekor) diberikan hanya PBS dan adjuvan saja, dan 
bertindak sebagai kontrol yang tidak divaksin. Satu minggu setelah vaksinasi terakhir, semua kambing ditantang dengan 2000 
tungau hidup pada daun telinga. Perkembangan lesi diamati pada hari pertama dan ke dua, lalu setiap minggu dari minggu 
pertama sampai ke delapan. Setiap kambing ditimbang dan sampel darah diambil setiap minggu, dan pada akhir percobaan 
kerokan kulit diambil untuk menetapkan populasi tungau. Respon antibodi akibat vaksinasi dan infestasi tantang diperiksa 
dengan ELISA dan Western Blotting. Hasil penelitian ini menunjukkan bahwa vaksinasi dengan fraksi protein nirlarut tungau 
menyebabkan pembentukan antibodi dengan titer yang sangat tinggi terhadap protein tersebut, namun antibodi tersebut sama 
sekali tidak memberikan proteksi terhadap tantangan tungau. Uji tantang menyebabkan lesi pada kelompok kambing yang 
divaksin yang keparahannya sama dengan yang terdapat pada kambing yang tidak divaksin. 
Kata Kunci: Sarcoptes scabiei, Protein Nirlarut, Kambing, Vaksinasi 
ABSTRACT 
TARIGAN, S. 2005. Protective value of immune responses developed in goats vaccinated with insoluble proteins from Sarcoptes 
scabiei. JITV 10(2): 118-126. 
Vaccines developed from certain membrane proteins lining the lumen of arthropod’s gut have been demonstrated effective in 
the control of some arthropod ectoparasites. A similar approach could also be applied to Sarcoptes scabiei since this parasite also 
ingests its host immunoglobulins. To evaluate immune protection of the membrane proteins, insoluble mite proteins were 
fractionated by successive treatment in the solutions of 1.14 M NaCl, 2% SB 3-14 Zwitterion detergent, 6 M urea, 6 M 
guanidine-HCl and 5% SDS. Five groups of goats (6 or 7 goats per group) were immunised respectively with the protein 
fractions. Vaccination was performed 6 times, each with a dosage of 250 µg proteins, and 3 week intervals between vaccination. 
Group 6 (7 goats) received PBS and adjuvant only, and served as an unvaccinated control. One week after the last vaccination, 
all goats were challenged with 2000 live mites on the auricles. The development of lesions were examined at 1 day, 2 days, and 
then every week from week 1 to 8. All animals were bled and weighed every week, and at the end of the experiment, skin 
scrapings were collected to determine the mite burden. Antibody responses induced by vaccination and challenge were examined 
by ELISA and Western blotting. This experiment showed that vaccination with the insoluble-protein fractions resulted in the 
development of high level of specific antibodies but the responses did not have any protective value. The severity of lesions and 
mite burden in the vaccinated animals were not different from those in the unvaccinated control. 
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INTRODUCTION 
Ivermectin, the drug of choice for scabies, is so 
effective and practical that has thwarted our endeavour 
to search for a better means of disease control. 
However, the consumer of food products are getting 
increasingly demanding that the food supply should be 
free of all chemical residues, whether or not they are 
known to be harmful to their health or environment 
(DONALD, 1994). Therefore, sooner or later, ivermectin 
will face strong consumer resistance because this 
acaricide is not environmentally friendly, and has a long 
withdrawal period. It has been demonstrated that 
animals injected with ivermectin contained the drug in 
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their excretes that kills a variety of important dung-
colonising insects (WALL, 1992). Prolonged and 
improper use of any pesticide have the potential to 
promote resistance of the parasite against the pesticide. 
The occurrence of resistance of S. scabiei against 
ivermectin has been reported recently (CURRIE et al., 
2004). New pesticide become increasingly difficult to 
be available in the market because the cost of product 
discovery and development, registration and market 
introduction are expensive; whereas, market for 
insecticides against livestock pests is small 
(WILLADSEN, 1997). In addition, ivermectin is 
expensive and unaffordable by most farmers in 
Indonesia. Other pesticides especially those applied 
topically are either ineffective or unpractical for use in 
the control of scabies in animals. 
In view of the negative aspect of the acaricides, 
alternative methods of control have to be sought. 
Vaccination is considered to be the most appropriate 
because it is safe for the consumers and environment, 
has long live immunity and potentially cheaper. 
However, developing vaccine against the parasites is 
much more difficult because of the complex interaction 
between the parasites and the immune system of the 
host. For S. scabiei, the difficulty is further exaggerated 
by the microscopic size and unavailability of culture 
system to produce sufficient amount of mites for the 
isolation of vaccine antigens. Because of those 
difficulties, the availability of practical anti-scabies 
vaccine will require considerable lengthy of time. 
Developing an anti-arthropod vaccine comprises at 
least three main steps: (i) identification and purification 
of protective antigens, (ii) production of functional 
recombinant version of the protective antigen, and (iii) 
formulation of the functional recombinant antigen into 
practical vaccine. Based on the exposure to the host 
immune system, vaccine antigens for ectoparasite could 
either be conventional antigens ie. parasite molecules to 
which the host is exposed during a normal host-parasite 
interaction, or ‘concealed’ antigens ie. parasite 
molecules to which the host is not exposed during 
natural infestation but when the host is immunised 
artificially with the molecules, it may confer protective 
immunity ( WILLADSEN, 1997).  
Our previous studies showed that vaccination of 
goats with soluble mite proteins that contained the 
conventional antigens did not conferred protective 
immunity, despite the high titre of specific IgG 
(TARIGAN and HUNTLEY, 2005). The lack of protective 
immunity is considered to be associated with the fact 
that vaccination fail to induce specific IgE. Experience 
with other multicellular parasites such as Boophilus 
microplus, Haemonchus contortus, and Lucilia cuprina 
indicated that a more complete protection was obtained 
by vaccination with concealed antigens than that with 
conventional antigens (WILLADSEN, 2001). Similar 
approach may also be feasible with S. scabiei since our 
previous studies indicated that S. scabiei does ingest its 
host immunoglobulin, despite the fact that this mite is 
not blood-feeding arthropod and reside on the 
avascular, cornified layer of skin (TARIGAN, 2005). In 
this present study, the insoluble mite proteins that 
expected to contain the concealed antigens were 
fractionated by successive solubilisation in the various 
solution of surfactants and chaotrophic agents of 
increasing solubility, then the capacity of each fraction 
to confer protective immunity was determined by 
vaccination and challenge experiment. 
MATERIALS AND METHODS 
Preparation of immunogen 
Sarcoptes scabiei mites were cultivated and 
harvested according to a procedure described in our 
previous study (TARIGAN, 1998). Briefly, goats severely 
infested by the mites, were euthanised with ether and 
chloroform, and skin showing encrustation dermatitis 
was scraped deeply. The scraping was chopped into 
about 2-mm3 pieces, mixed thoroughly and kept at 4°C 
overnight. To harvest the mites, the skin scrapings were 
placed at the edge of a Petri disc, then a beam of light 
was directed to the centre of the Petri disc. Mites 
migrating toward the light were collected by sucking 
into a special tube that attached to a vacuum pump. 
After washing in 1% SDS, the mites, approximatey 
15 gram in wet weight, were homogenised in PBS using 
a glass homogeniser. The homogenate was centrifuged 
at 8 000 x g for 30 minutes at 4ºC, then the pellet was 
collected and washed twice with PBS. Extraction of 
insoluble or membrane proteins from the mite pellet 
was performed by a previously described procedure 
with some modification (RIDING et al., 2000). Briefly, 
the pellet was homogenised and incubated sequentially 
in the extraction solutions of 1.14 M NaCl for 2 hours, 
2% SB 3-14 zwitterion detergent (N-tetradecyl-N, N-
dimethyl-3-ammonio-1-propane sulphonate) for 2 
hours, 6 M urea for 18 hours, and 6 M guanidine-HCl 
for 18 hours. Following each extraction, the 
homogenates were subjected to ultracentrifugation (100 
000 x g for 1 hour at 4ºC) followed by resuspension of 
the pellet in the next extraction solution. Supernatants 
obtained after each centrifugation were collected and 
referred to as fractions FNaCl, FZwit, Furea, FGuan, 
respectively. The pellet obtained after the extraction 
with guanidine solution was washed twice with double 
distilled water and twice with 50 mM Tris-HCl, pH 7.5. 
After the washings, the pellet was homogenised in 50 
mM Tris-HCl, pH 7.5 containing 5% SDS and 10 mM 
dithiothreitol (DTT). The homogenate was heated at 
95ºC for 30 minutes then centrifuged at 25ºC for 1 hour 
at 100 000 x g at 25ºC. The supernatant was collected 
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and referred to as FSDS. After determination of protein 
concentrations with a commercial Lowry protein assay 
kit (RCTM protein assay, BioRad), each fraction was 
aliquoted and stored at -20ºC until used.  
Animals and vaccination 
Forty goats were allocated randomly into 6 groups, 
group 1 (7 goats), group 2 (7 goats), group 3 (7 goats), 
group 4 (6 goats) and group 5 (6 goats) were vaccinated 
respectively with FNaCl, FZwit, Furea, Fguan and FSDS. 
Group 6 (7 goats) were injected with PBS and served as 
an unvaccinated control. Vaccination was conducted 6 
times, 3 week intervals between vaccination, and a dose 
of 250 µg protein per vaccination. Quil A with a dose of 
0.5 mg was used in all vaccination. 
Challenge and post challenge examination 
One week after the last vaccination, all animals 
were challenged with approximately 2000 live mites on 
the left auricles using a procedure described previously 
(TARIGAN, 2003). Briefly, skin scraping was collected 
from a mangy goat, chopped into about 2-mm3 pieces, 
and mixed thoroughly. The number of mite per gram of 
skin scraping was determined by placing the skin 
scraping at the edge of a Petri disc. A beam of light was 
directed to the centre of the Petri disc, and mites 
migrating toward the light were counted under a 
microscope after 6 hours. A piece of cloth (6 x 4 cm2) 
was placed on the convex surface of a goat auricle, the 
bottom, left and right rims of the cloth were attached to 
the auricle by adhesive tapes. Skin scraping containing 
approximately 2000 mites was inserted under the cloth 
through the top edge then the top edge was attached to 
the auricle.  
After 48 hours, the cloth together with the skin 
scraping were removed and infestation was allowed to 
progress. Skin lesions caused by the mite challenge 
were photographed and assessed their severity at 1 day, 
2 days, then at weekly intervals from one to eight week. 
The severity of lesions were determined by the 
following scores: score 0 if no lesion, 1 if <10% of the 
infected auricles affected by dermatitis, score 2 if 10-
50% were affected, score 3 if >50-100 %, and 4 if the 
lesions affected not only the infested auricles but also 
skin of other parts of the body. The effect of mite 
infestation on body condition was assessed from the 
changes in the body weight which were measured 
weekly before and after challenge. 
Enzyme-linked immuno-sorbent assay (ELISA) 
The development of specific antibodies in animals 
was quantified by ELISA using antigens containing 
protein fraction with which the tested animals were 
vaccinated. A checkerboard titration was performed to 
determine the optimal concentration of coating antigen, 
test serum and secondary antibody. A dilutions that 
gave the lowest optical density (OD) with serum from 
non-infected (control) goats, and the highest OD ratio 
between positive serum (from severely-infested goats) 
and the control serum were chosen and used to assay 
the sample sera.  
The wells of polystyrene microtitre plates 
(Maxisorp, Nunc™, Denmark) were coated overnight at 
room temperature (28ºC) with 100 µl of the antigen 
diluted in 0.1 M carbonate buffer pH 9.6 (4-8 µg 
proteins/well). After washings the wells twice with 
PBST (PBS containing 0.05% Tween 20), duplicate 100 
µl volume of the sera to be tested, diluted 1:200 in PBS, 
were added to the wells and incubated for 1 hour at 
room temperature. Following washings, wells were 
incubated for 1 hour with HRP-conjugated-donkey-anti-
goat IgG (Jackson Immuno Research Laboratories, PA, 
USA) diluted 1: 20,000 in PBS. Washed plates were 
developed in the dark for 30 minutes with a 
chromogenic/substrate of ABTS and the resulting green 
colour was quantitated at 405 nm using a microtitre-
plate reader. 
Immunoblotting 
Washed mites were homogenised in Laemmli 
reducing SDS-PAGE sample buffer (65 mg of mites/ml 
buffer) and heated for 10 minutes at 95ºC. Insoluble 
materials were pelletted by centrifugation and a 75-µl 
portion of the supernatant was loaded into the large well 
of a two-well, 0.75-mm-thick comb of Mini-Protean 3 
cells (BioRad Laboratories). The small well was loaded 
with 5 µl prestained-molecular-weight marker 
(Amersham Biosciences). The stacking and the 
separating gels contained 4 and 12% monomer of 
acrylamide, respectively. Electrophoresis was carried 
out through the gels at 100 volts until the leading dye 
reach about 1.5 cm above the bottom of the gel. After 
electrophoresis, proteins from the acrylamide gel were 
transferred onto a nitrocellulose membrane using 
transfer buffer consisting of 25 mM Tris, 192 mM 
glycine, 20% methanol in an electrophoretic transfer 
cell (MiniTransblot, Bio-Rad Laboratories) at 100 volts, 
350 mA for 2 hours. After the transfer, the membrane 
was cut into 5-mm-wide strips then soaked for 2 hours 
in 0.1% solution of non-fat skim milk to blocked 
unoccupied sites in the membrane. The strips were 
reacted for 2 hours with goat sera at 1:1000 dilution in 
PBS for 2 hours. After washing five times, the 
membrane strips were incubated for 2 hours in alkaline-
phosphatase-labelled-anti-goat-mouse-monoclonal 
antibody (Sigma) at 1: 5, 000 dilution in PBS. After 
washing, the membrane strips were developed in 
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NBT/BCIP substrates according to the procedures 
provided (Sigma-Aldrich Pte, Singapore). 
Mite burden 
At the end of challenge schedule (8 weeks after the 
initial mite infestation), the auricles were cut off at 5 cm 
from the tip, after previously had been infiltrated with a 
local anaesthetic, Lidocaine-HCl. After the biopsy, the 
incision site was sutured, smeared with an anti-septic 
solution (Betadine®) and sprayed with a screw-worm-
and-wound-dressing spray (Gusanex®). The detached 
auricles was stored at -20ºC to be used for mite count. 
The skin from the auricles that stored at -20ºC were 
scraped on an area of 2 cm2 and the scrapes were 
suspended in 20% KOH for 30 minutes. The scrape 
suspension was poured on a 2 mm2-grid and the number 
of mites were counted under a light microscope and 
mite burden was expressed as number of mite per cm2 
skin surface. 
Statistical analysis 
Protective value of immune response elicited by the 
vaccination was based on the severity of lesions caused 
by the mite challenge, mite densities, titre of specific 
antibody and changes in body weight. Differences in 
the score of lesions between group of goats were 
analysed using a non-parametric analysis, Kruskal-
Wallis one-way ANOVA (PETRIE and WATSON, 2001). 
Differences in the antibody titres, body weight changes 
and mite densities were analysed with one-way 
ANOVA (PETRIE and WATSON, 2001). The data of mite 
densities which were expressed in number of mites/cm2 
were first transformed into their logarithmic value 
before analysed with one-way ANOVA (PETRIE and 
WATSON, 2001). When differences between groups 
were statistically significant at P<0.05, Tukey’s 
multiple comparison analysis were performed.  
RESULTS 
The SDS-PAGE profile of fraction of insoluble 
proteins from the S. scabiei is presented in Figure 1. 
Each fraction that contained a large number of proteins 
with molecular weights ranged from less than 10 to 
over 100 kDa has a distinct profile. All of the fractions 
were immunogenic as high level of specific antibodies 
were conferred by animals vaccinated with the 
fractions.  
In general, the prevaccinated and unvaccinated 
control animals did not recognised the insoluble mite 
proteins (Figure 2). Some animals, however, recognised 
faintly same of the proteins but the recognition was not 
intensified by the vaccination and mite challenge. This 
stable reaction, therefore, argued the possibility that 
those goats had previously been exposed to scabies. 
Sera collected after the last vaccination recognised a 
great number of mite proteins and differences were 
observed between group of animals. Blots reacted with 
pre-challenge vaccinated sera produced signals which 
were obviously stronger than those with post-challenge 
unvaccinated sera, indicating that the level of
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. SDS-PAGE protein profile of insoluble-mite-protein fractions. Sol = soluble mite proteins, NaCl = FNaCl, Zwit = FZwit, 
Guan = FGuan, SDS= FSDS 
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Figure 2. Immunoblot of SDS-PAGE-fractionated total mite proteins against sera of animals collected before vaccination (Pre-
vaccination), after the 6th vaccination (post-vaccination) and 8 week post mite challenge (post-challenge). Line 1: the mite 
proteins were reacted with pooled sera from unvaccinated control goats, line 2, 3, 4, 5 and 6 with pooled sera of group of 
goats respectively vaccinated with FNaCl, Fzwit, Furea, FGuan and FSDS 
antibodies conferred by the vaccination were very high 
because they were higher than that induced by severe 
natural infestation. Although the majority of antigens 
recognised by the pre-challenge-vaccinated sera were 
also recognised by the post-challenge-unvaccinated 
controls, differences in the antigen recognition by the 
two groups were obvious. Antigens with estimate Mr of 
47, 32 and 29 KDa which were recognised strongly by 
all groups of pre-challenge vaccinated animals were not 
recognised by any of the post-challenge-unvaccinated 
animals. These antigens, therefore, were considered to 
be major, novel or concealed antigens of S. scabiei. A 
protein with an estimate Mr of 53.6 KDa which was 
recognised strongly by the post-challenge unvaccinated 
group and pre-challenge FNaCl group was only 
recognised faintly by the pre-challenge vaccinated-
animals. This may indicate that this protein was likely 
to be highly water soluble and one of the major antigens 
in the normal parasite-host interaction. 
Quantification of the specific antibodies by the 
ELISA showed that the level of specific antibodies, as 
indicated by OD increases, were increased after each 
vaccination. However, the OD increases were small 
with the maximum increases of only two or three folds 
over the base line (Figure 3). Also with unknown reason 
the ODs dropped in all vaccinated animals after the 
fourth and fifth vaccination, and the drop varied 
significantly between groups. These phenomena, 
however, were unseen in the immunoblot assay. 
Despite strong immune responses developed in the 
vaccinated animal, the immune responses did not have 
any protective value. Challenge of the goats with S. 
scabiei one week following the last vaccination resulted 
in the development of severe acute dermatitis at the 
infested auricles in all goats. Twenty-four to 48 hours 
following infestation, the infested auricles in most goats 
became severely swollen (Figure 4A). When palpated, 
the affected auricles were tender, soft in consistency, 
and appeared much hotter than the opposite auricles. 
Serous exudates were observed at the site of infestation 
especially on auricles previously severely swollen, and 
numerous small papules under the coat at or around the 
site of infestation were perceived when the auricles 
were palpated. Differences in nature or severity of the 
lesions, however, were not discernible between 
unvaccinated control and vaccinated groups, or within 
the vaccinated groups. Examination at 1-week revealed 
that the swelling and exudation had disappeared from 
all animals leaving patches of alopecia or thinning or 
hair. The infested auricles were covered by either dried 
serum crusts or thin parakeratotic scales. The crusts and 
scales were thickened and spread rapidly and more than 
halve the auricle surface was affected by two weeks 
post infestation in most animal (Figure 4B). By 3 
weeks, practically the entire surface of the infested 
auricles had been covered by thick crusts or scab 
formation, and the lesions started to spread to other 
regions of the body, particularly to the shoulder, neck, 
head and opposite auricle (Figure 4C). At the end of 
experiment (8 week post infestation), practically the 
whole skin was affected. Again, no differences in 
severity of lesions could be discernible between 
unvaccinated control and vaccinated groups (Figure 
4D). 
The effects of mite challenge on body weight 
changes in the unvaccinated-control and vaccinated 
groups are presented in Table 1. Except for Fzwit-group 
goats at two week post challenge, no reduction in body 
weight was observed in any group of the goats. No 
significant differences in the body weight changes 
between vaccinated and non vaccinated goats were 
observed. The mean body weight increases in goats of 
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FNaCl-group were found to be significantly higher than 
that of Fzwit-group but those differences did not 
associated with severity of lesions as no differences in 
the severity were observed.  
In agreement with severity of lesions and body-
weight changes, the mite burdens or mite densities in 
the vaccinated groups were not different from that in 
the unvaccinated control (Figure 5). For unknown 
reason, the number of eggs in the FSDS-group was 
significantly higher than that in the FGuan-group. 
 
Figure 3. Antibody response of goats monitored with ELISA against vaccination and mite challenge. NaCl = FNaCl, Zwit = FZwit, 
Guan = FGuan, SDS= FSDS. V1 to V6 represent first to sixth vaccinations respectively 
 
Figure 4. Lesions developed after mite challenge. Severe swelling in the infested auricle (arrow) two days post challenge (A), 
dermatitis with thick sero-cellular exudates two-weeks (B) and 3 weeks post challenge (C). Severe encrustation dermatitis 
affecting almost the entire skin (D). Note: no differences in the severity of lesions between vaccinated and unvaccinated 
groups 
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Table 1. Change in the body weight of goat after challenge 
Time  
Group 
2 week 4 week 6 week 8 week 
Unvaccinated 0.52 1.05 1.02 1.45 
FNaCl 1.43b 2.10b 2.08b 2.00 
FZwit -0.06a 0.71a 0.40a 0.54 
FUrea 0.91 1.66 2.03b 2.20 
FGuan 1.07 1.66 1.90 2.43 
FSDS 1.02 1.45 1.58 1.78 
Note: different superscript indicate significantly different (P<0.05) 
 
 
Figure 5. The density of mites (number of mites/cm2) on the right auricle. No differences between groups were found, except that 
the density of eggs in the SDS group was significantly higher (P=0.002). NaCl = FNaCl, Zwit = FZwit, Guan = FGuan, SDS= 
FSDS. 
DISCUSSION 
These studies show that immune responses elicited 
by immunisation of goats with insoluble proteins 
extracted from S. scabiei did not protect the animals 
from mite challenge. The lack of protective immunity in 
any group of animals after immunizing with the 
insoluble mite proteins was disappointing. We had 
assumed that membrane proteins lining the lumen of the 
mite’s gut would be extracted by the surfactants or 
chaotrophic agents, and therefore the proteins should be 
present in one or more of the fractions. Therefore, it 
was expected that animals vaccinated by the fraction 
should induce specific antibodies, and when ingested by 
mites, the antibodies would inactivate the function of 
the membrane proteins which in turn caused mortality 
or severe damage to the mites. This expectation was 
based on our previous experiment which indicates that 
S. scabiei, despite residing not deeper than the cornified 
layer of the skin, does ingest its host immunoglobulin 
(TARIGAN, 2005).  
At the time of challenge, all vaccinated animals had 
a high level of antibodies. This is not a surprise since 
the animals had been vaccinated six times. The high 
number of vaccination is to anticipate the possibility of 
low abundance of protective antigens in the fractions. 
The high level of antibodies were obvious when 
examined by immunoblot analysis but not so clear when 
examined with the ELISA. The inaccuracy of the 
ELISA is thought to be resulted from the inadequate 
binding of the mite-insoluble proteins to the 
polysterene-microplate wells. This limited binding is 
probably associated with the insoluble nature of the 
proteins in the coating buffer used. 
The lack of protection conferred by the vaccination 
protocol may result from a number of possibilities. 
First, the protective membrane proteins might have not 
been extracted by any of the surfactants or chaotrophic 
agents although the method has been successfully used 
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in the extraction of protective membrane proteins from 
screw-worm fly (RIDING et al., 2000). This possibility 
seems unlikely since a number of surfactants and 
chaotrophic agents were used included those with high 
solubilisation capacity. All membrane proteins should 
be solubilised at least in the SDS solution. Second, the 
protective membrane may have been degraded by 
proteolytic enzymes. During homogenisation of the 
mites, anti serine-proteases, anti cysteine-protease and 
anti metallo-proteases were included in the extraction 
buffer (TARIGAN and HUNTLEY, 2005). Therefore, 
soluble proteases should have been inactivated. 
However, during fractionation of the water-insoluble 
proteins the anti proteases, for technical reasons, were 
not included. It is also unlikely that the remaining 
proteases should be still active under such high 
concentration of the surfactants and chaotrophic agents. 
Third, protective membrane proteins underwent 
coagulation during fractionation which in turn resulted 
in the loss of protective capacity. Fourth, the mites did 
not ingested the host immunoglobulin sufficiently or the 
protective membrane proteins exist in such low 
abundance that incapable of conferring sufficient 
protective immunity. If this later possibility is true, 
then, the protective proteins must exist in an extremely 
low concentration since six time vaccination is still 
unable to induce immune protection. The contention 
that protective concealed antigens exist in extreme low 
concentration is supported by the findings in Boophilus 
microplus. To purified several milligram of protective 
concealed antigen, Bm 86, required nearly 1 kg of ticks 
as the starting materials (WILLADSEN et al., 1989).  If 
such low concentration also happened in S. scabiei, the 
amount of protective antigen received by each 
vaccinated animals must have been too low to confer 
detectable protective immunity. 
The criteria for the protective immunity as used in 
this study was the reduction in the severity of lesions 
and mite burden in the vaccinated individuals, as 
compared to those in the unvaccinated control. These 
criteria may not be satisfactory since ectoparasite 
vaccines that have been developed so far are not 
intended to protect the vaccinated individual nor to 
knock down invading parasite immediately but rather to 
reduce ectoparasite population over successive parasite 
generation in an area-wide management programme 
(PRUETT, 1999). Nevertheless, there is no reason to 
believe that repeated vaccination with the mite-
insoluble protein will cause reduction in the mite 
population since no difference in mite burden between 
vaccinated and unvaccinated animals. 
CONCLUSSION 
To sum up, the protective-concealed antigens from 
S. scabiei are either very labile or exist in extreme low 
concentrations that their protective capacities are 
undetectable by conventional biochemical fractionation 
and vaccination-challenge experiment. 
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